Resultados de la búsqueda 201-210 of 10305 for Cycle

  1. Neurocirugía - Ensayos clínicos

    ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    ... cycles of mosunetuzumab. An additional arm (open to non-US participants only) has been added to assess the safety, tolerability, pharmacokinetics, and ...

  3. Neurología - Ensayos clínicos

    ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...

  4. Neurocirugía - Ensayos clínicos

    ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...

  5. Neurología - Ensayos clínicos

    ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...

  6. Neurología - Ensayos clínicos

    ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...

  7. Neurología - Ensayos clínicos

    ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...

  8. Programa de tumores cerebrales - Ensayos clínicos

    ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...

  9. Neurología - Ensayos clínicos

    ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...

  10. Oncología (médica) - Ensayos clínicos

    ... cycles of mosunetuzumab. An additional arm (open to non-US participants only) has been added to assess the safety, tolerability, pharmacokinetics, and ...